Clinical Efficacy of Acupuncture Combined With Acupoint Patching in Treating Chronic Pelvic Pain as a Sequela of Pelvic Inflammatory Disease

DUN Juyan, WANG Fen, TIAN Liying

Abstract

To investigate the efficacy of acupuncture therapy combined with acupoint patching in alleviating chronic pelvic pain, a sequela of pelvic inflammatory disease (SPID-CPP).

Methods 

A total of 120 SPID-CPP patients attending our hospital between January 2022 and November 2024 were enrolled and randomly assigned to either an experimental group or a control group, with 60 patients in each group. Both groups received conventional lifestyle guidance and anti-infection therapy. The control group received only acupuncture therapy, while the observation group received acupuncture combined with acupoint patching therapy. The duration of treatment was identical for both groups. The treatment effect, levels of high-sensitivity C-reactive protein (hs-CRP), white blood cell count (WBC), neutrophil percentage (NEUT), fibrinogen (FIB) level, quality-of-life scores, and visual analog scale (VAS) pain scores were compared between the experimental and control groups.

Results 

The treatment efficacy rate of the experimental group was 93.00%, while that of the control group was only 73.33%, and the difference between the two groups was statistically significant (P < 0.05). Following therapy, the hs-CRP, WBC, NEUT, and VAS ratings of both the control and experimental groups decreased. Furthermore, findings of the experimental group were significantly lower than those of the control group (P < 0.05). The quality-of-life score of the experimental group was higher than that of the control group (P < 0.05).

Conclusion 

Acupuncture combined with acupoint patching demonstrates significant efficacy in treating SPID-CPP. This combined therapy effectively reduces pain in SPID-CPP patients, decreases serum levels of inflammatory factors, and significantly improves patients' quality of life.

 

Keywords: Acupuncture, Acupoint patching, Sequelae of pelvic inflammatory disease, Chronic pelvic pain

 

Full Text:

PDF


References


YAN X, TONG L L, SUN X C, et al. Analysis of pathogen distribution and drug resistance in female pelvic abscesses. Chin J Exp Diag, 2022, 26(2): 232-234. doi: 10.3969/j.issn.1007-4287.2022.02.021.

HU Y, YU Y L, TANG L. Penyan pill combined with thunder fire moxibustion in patients with sequelae of pelvic inflammatory disease: a randomized controlled trial. Chin J Pharmacoepidemiol, 2025, 34(2): 144-150. doi: 10.12173/j.issn.1005-0698.202412060.

FROCK-WELNAK D N, TAM J. Identification and treatment of acute pelvic inflammatory disease and associated sequelae. Obstet Gynecol Clin North Am, 2022, 49(3): 551-579. doi: 10.1016/j.ogc.2022.02.019.

HUNT S, VOLLENHOVEN B. Pelvic inflammatory disease and infertility. Aust J Gen Pract, 2023, 52(4): 215-218. doi: 10.31128/AJGP-09-22-6576.

PUISSANT G, FELLAH L, PERLEPE V. Multimodality imaging of pelvic inflammatory disease complicated with tubo-ovarian abscess. J Belg Soc Radiol, 2023, 107(1): 20. doi: 10.5334/jbsr.3061.

JENNINGS L K, KRYWKO D M. Pelvic inflammatory disease. Treasure Island (FL): StatPearls Publishing LLC, 2025.

ZHANG Q, YANG G, XIONG Y, et al. Impact of antibiotic cured chronic endometritis on perinatal outcomes: re-evaluation of a cohort study with a detailed follow-up. Am J Reprod Immunol, 2023, 90(2): e13751. doi: 10. 1111/aji.13751.

YANG L, LI Y, ZHANG S, et al. Efficacy of acupuncture combined with traditional Chinese medicine fumigation therapy in sequelae of pelvic inflammatory disease: a systematic review and meta-analysis. Complement Med Res, 2024, 31(2): 175-186. doi: 10.1159/000536101.

IWATA H, SUGIYAMA Y, SATOI Y, et al. Diagnostic accuracy of pelvic examination in pelvic inflammatory disease: a meta-analysis. J Gen Fam Med, 2022, 23(6): 384-392. doi: 10.1002/jgf2.572.

YAN N, LEI L, LIU H T, et al. Research progress in the etiology and pathogenesis of chronic pelvic inflammatory disease in traditional Chinese medicine and treatment based on syndrome differentiation. J Changchun Univ Chin Med, 2024, 40(6): 700-703. doi: 10.13463/j.cnki. cczyy.2024.06.025.

ÅSTRÖM M, THET LWIN Z M, TENI F S, et al. Use of the visual analogue scale for health state valuation: a scoping review. Qual Life Res, 2023, 32(10): 2719-2729. doi: 10.1007/s11136-023-03411-3.

GERMANOVA O A, VUKOLOVA Y Y, STRELNIK A, et al. Application of SF-36 health status survey in patients with arterial hypertension. Psychiatr Danub, 2023, 35(Suppl 2): 318-321.

LI X, ZHENG H, ZHOU Z, et al. Clinical effect of Mudan granule on peripheral neuritis caused by chronic renal insufficiency. Comput Math Methods Med, 2022, 2022: 1052744. doi: 10.1155/2022/1052744.

LI Z F, QIAN L, XU D D. Research progress on sequelae of pelvic inflammatory disease treated with traditional Chinese medicine. Shaanxi J Tradit Chin Med, 2024, 45(10): 1431-1434. doi: 10.3969/j.issn.1000-7369. 2024.10.031.

TANG J, WU P, YU Z Y, et al. Research progress on the effects of acupuncture and moxibustion on pain regulating neurotransmitters of reward system in the treatment of chronic pain. Chin J Tradit Chin Med, 2022, 37(3): 1570-1573.

ZENG X L, YANG X A, LI S S, et al. Current status of the mechanism of acupuncture in the treatment of chronic pain and depression comorbidity. Shanghai J Acupunct Moxibust, 2024, 43(11): 1284-1290. doi: 10.13460/j.issn.1005-0957.2023.13.0041.

YANG C X, DI Z F, LIU X, et al. The impact of acupuncture combined with Nei Yang Gong on pelvic mass diameter and uterine artery hemodynamic parameters in patients with chronic pelvic inflammation. Liaoning J Tradit Chin Med, 2024, 51(1): 183-187. doi: 10.13192/j.issn. 1000-1719.2024.01.047.

GUO X, ZHOU M J, FAN F T, et al. A randomized controlled study of acupuncture moxibustion powder moxibustion for the pre-stage of bronchial asthma. Chin Gen Pract, 2025, 28(11): 1367-1375. doi: 10. 12114/j.issn.1007-9572.2024.0044.

PENG G, ZHENG Y, LUO D. Effects of acupuncture and moxibustion combined with needle-knife on pain and lumbar function in patients with lumbar disc herniation. J Healthc Eng, 2022, 2022: 9185384. doi: 10.1155/ 2022/9185384.

QIAN Y, LIU X, FENG Y, et al. Tenascin C regulates cancer cell glycolysis and tumor progression in prostate cancer. Int J Urol, 2022, 29(6): 578-585. doi: 10.1111/iju.14830.


Refbacks

  • There are currently no refbacks.